Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany; CBBM (Center of Brain, Behavior and Metabolism), Lübeck, Germany.
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany; CBBM (Center of Brain, Behavior and Metabolism), Lübeck, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany.
Pharmacol Res. 2017 Nov;125(Pt A):72-90. doi: 10.1016/j.phrs.2017.06.016. Epub 2017 Jul 5.
Cardiovascular diseases (CVD) are among the main causes of death globally and in this context hypertension represents one of the key risk factors for developing a CVD. It is well established that the peripheral renin-angiotensin system (RAS) plays an important role in regulating blood pressure (BP). All components of the classic RAS can also be found in the brain but, in contrast to the peripheral RAS, how the endogenous RAS is involved in modulating cardiovascular effects in the brain is not fully understood yet. It is a complex system that may work differently in diverse areas of the brain and is linked to the peripheral system by the circumventricular organs (CVO), which do not have a blood brain barrier (BBB). In this review, we focus on the brain angiotensin peptides, their interactions with each other, and the consequences in the central nervous system (CNS) concerning cardiovascular control. Additionally, we present potential drug targets in the brain RAS for the treatment of hypertension.
心血管疾病 (CVD) 是全球范围内主要的死亡原因之一,而高血压是导致 CVD 的关键风险因素之一。外周肾素-血管紧张素系统 (RAS) 在调节血压 (BP) 方面发挥着重要作用,这一点已得到充分证实。经典 RAS 的所有成分也存在于大脑中,但与外周 RAS 不同,内源性 RAS 如何参与调节大脑中的心血管效应尚不完全清楚。这是一个复杂的系统,在大脑的不同区域可能有不同的作用方式,并通过无血脑屏障 (BBB) 的室周器官 (CVO) 与外周系统相连。在这篇综述中,我们重点关注脑血管紧张素肽,它们之间的相互作用以及它们对心血管控制的中枢神经系统 (CNS) 的影响。此外,我们还介绍了大脑 RAS 中的潜在药物靶点,以治疗高血压。